MedPath

Transderm Scop

Transderm Scōp

Approved
Approval ID

f6fdc88b-ea00-4694-8f21-b8d15dbb339e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 26, 2013

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

scopolamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-2803
Application NumberNDA017874
Product Classification
M
Marketing Category
C73594
G
Generic Name
scopolamine
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateMarch 26, 2013
FDA Product Classification

INGREDIENTS (5)

SCOPOLAMINEActive
Quantity: 1 mg in 3 d
Code: DL48G20X8X
Classification: ACTIB
LIGHT MINERAL OILInactive
Code: N6K5787QVP
Classification: IACT
POLYISOBUTYLENE (35000 MW)Inactive
Code: 98553S1MHQ
Classification: IACT
POLYISOBUTYLENE (1100000 MW)Inactive
Code: FLT10CH37X
Classification: IACT
CHLOROFORMInactive
Code: 7V31YC746X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Transderm Scop - FDA Drug Approval Details